Answers are grounded in this paper and cite their sources.
Background: A shortage of donor livers for transplant has led to an increased interest in cell therapeutics as an alternative to whole organ transplant to treat end-stage liver disease. Primary human hepatocytes have been used in cell-based therapies. However, hepatocytes do not proliferate in vitro so it is challenging to grow enough cells for a successful transplant. Many have suggested using hepatocyte-like Adipose-derived mesenchymal Stromal/ stem Cells (ASCs) differentiated into hepatocyte-like cells as a substitute. Here we evaluate how closely these cells resemble primary hepatocyte cell morphology and function.
No takes yet. Share an insight, caveat, or question.
Ramon et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: